| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/04/2009 | US20090142261 EPHB3-Specific Antibody and Uses Thereof |
| 06/04/2009 | US20090142259 Compositions and methods for the diagnosis and treatment of bladder and urinary tract tumors |
| 06/04/2009 | CA2706855A1 Bioengineered tissue constructs and methods for production and use |
| 06/04/2009 | CA2706560A1 Differentiation of human embryonic stem cells |
| 06/04/2009 | CA2706479A1 14-3-3 antagonists for the prevention and treatment of arthritis |
| 06/04/2009 | CA2706429A1 Compositions for treating an intestinal inflammatory condition |
| 06/04/2009 | CA2706419A1 Antigen-binding constructs |
| 06/04/2009 | CA2704704A1 Composition comprising calcium ions and at least one proteolytic enzyme for use in the in vitro and in vivo regeneration of cutaneous and connective tissues |
| 06/03/2009 | EP2065468A1 Modifications of hiv env enhance immunogenicity for genetic immunization |
| 06/03/2009 | EP2065467A2 Anti-interferon-alpha antibodies |
| 06/03/2009 | EP2065464A1 Modulation of cytochrome P450 reductase activity |
| 06/03/2009 | EP2065463A2 Survival and development of neural cells |
| 06/03/2009 | EP2065462A1 Ex vivo method for producing a preparation containing CD4+ T cells specific for EBV structural antigens |
| 06/03/2009 | EP2065401A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065400A2 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 06/03/2009 | EP2065396A1 Interleukin-19 |
| 06/03/2009 | EP2065052A2 Anti-IgE vaccines |
| 06/03/2009 | EP2064333A2 Suppressor trna transcription in vertebrate cells |
| 06/03/2009 | EP2064320A2 Bone mineralization protein expression systems, and methods of studying their intracellular signaling pathways |
| 06/03/2009 | EP2064319A2 Methods of generating glial and neuronal cells and use of same for the treatment of medical conditions of the cns |
| 06/03/2009 | EP2064318A1 A method for producing langerhans cells and/or dermal/interstitial dentritic cells from cd14+ monocytes |
| 06/03/2009 | EP2064317A1 Isolation of cells |
| 06/03/2009 | EP2064316A2 Site specific incorporation of non-natural amino acids by vertebrate cells |
| 06/03/2009 | EP2064315A2 Glycolysis-inhibiting substances in cell culture |
| 06/03/2009 | EP2064314A2 Cell culture improvements |
| 06/03/2009 | EP2064244A2 ANTIBODIES DIRECTED TO alphaVß6 AND USES THEREOF |
| 06/03/2009 | EP2064226A2 Novel haplotype of human t2r receptor ht2r50 and its use in assays for identifying human bitter taste modulators |
| 06/03/2009 | EP2064224A2 Tissue culture system for production of hepatitis c virus |
| 06/03/2009 | EP2063902A1 Therapeutic cell medicine comprising skin tissue derived stem cell |
| 06/03/2009 | EP1981969A4 Gitr antibodies for the treatment of cancer |
| 06/03/2009 | EP1926812A4 Methods for rapidly and accurately locating avian egg blastoderms |
| 06/03/2009 | EP1913129A4 Cardiomyocyte cell populations |
| 06/03/2009 | EP1891206A4 Mass production of secondary metabolite in plant cell culture by treatment of saccharide mixture in medicum |
| 06/03/2009 | EP1889063A4 Nanoscale neuromodulating platform for retina neuron activation apparatus and method |
| 06/03/2009 | EP1817583A4 Glucose-transport related genes, polypeptides, and methods of use thereof |
| 06/03/2009 | EP1773485A4 Stable composite material comprising supported porous gels |
| 06/03/2009 | EP1733026A4 Tissue system with undifferentiated stem cells derived from corneal limbus |
| 06/03/2009 | EP1590452B1 Stable lipase variants |
| 06/03/2009 | EP1553172B1 Thermostable ribonuclease h |
| 06/03/2009 | EP1407017B1 Human tumor necrosis factor receptor |
| 06/03/2009 | EP1399472B1 Soluble heterodimeric cytokine receptor |
| 06/03/2009 | EP1131426B1 Mage-10 or mage-8 derived hla-a2.1-binding oligopeptides |
| 06/03/2009 | EP1111054B1 A new gene of human lysoenzyme, the encoding polypeptide and methods for preparing them |
| 06/03/2009 | EP1012283B1 Mage-3 peptides presented by hla class ii molecules |
| 06/03/2009 | EP0772677B1 T cell activation |
| 06/03/2009 | EP0763119B1 Soluble solids modification using sucrose phosphate synthase encoding sequences |
| 06/03/2009 | CN101448934A Panel cell used for granulocyte antibody detection |
| 06/03/2009 | CN101448933A Tenocyte cell culturing method |
| 06/03/2009 | CN101448932A Three dimensional cell culture |
| 06/03/2009 | CN101448527A Cell-matrix microspheres, methods for preparation and applications |
| 06/03/2009 | CN101445800A T1r taste receptors and genes encoding same |
| 06/03/2009 | CN101445793A Method for rapidly separating supernatant from human whole blood or suspended red blood cells by utilizing lyophilized preparation |
| 06/03/2009 | CN101445792A Cell co-culture method for inducing bone mesenchymal stem cells to differentiate into osteoblast |
| 06/03/2009 | CN101445791A Method for screening pluripotent cell and special culture medium thereof |
| 06/03/2009 | CN101445790A Cell system for generating somatic cells |
| 06/03/2009 | CN101445555A Antibodies to non-functional p2x7receptor, diagnosis and treatment of cancers and other conditions |
| 06/03/2009 | CN100494388C Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/03/2009 | CN100494378C Transgenic organism expressing fungal MRP-like ABC transporters |
| 06/03/2009 | CN100494363C Glycooxidase and its application in baking process |
| 06/03/2009 | CN100494361C Skin cell with anti-inflammatory activity, and its preparing method and use for skin infective wound surface |
| 06/03/2009 | CN100494360C Process for separating cells and its application |
| 06/03/2009 | CN100494359C Method for in vitro amplifying and in 3D solid culturing for nerve stem cell |
| 06/03/2009 | CN100494358C Vitrifiation freezing method for chicken embryo primordial germ cell |
| 06/03/2009 | CN100494357C Method for building poplar embryogenic cell generation technology system |
| 06/03/2009 | CN100494356C Method for breeding energy alga-kelp sporophyte using gametophyte clone method |
| 06/03/2009 | CN100494355C Method for promoting Chinese wildrye callus differentiation rate and its special medium |
| 06/03/2009 | CN100494354C Method of recovering cell on microvector from passive outer space carrier system |
| 06/03/2009 | CN100494345C Cell suspension culture and anchorage culture serum free medium and its preparation method |
| 06/03/2009 | CN100494344C New biopesticide using gene from erwinia pyrifoliaeWT#3, novel pathogen that affects asian pear trees |
| 06/02/2009 | US7541527 Plants and seeds of corn variety CV015152 |
| 06/02/2009 | US7541526 Inbred maize line PHF1J |
| 06/02/2009 | US7541525 Inbred maize line PHEDR |
| 06/02/2009 | US7541524 Inbred maize line PHDPP |
| 06/02/2009 | US7541523 Plants and seeds of corn variety I029427 |
| 06/02/2009 | US7541521 Inbred corn line PHCAM |
| 06/02/2009 | US7541449 DNA segment encoding the enzyme inhibitor for therapy of thrombosis, blood disorders; biodrugs; genetic vaccines; monoclonal antibodies; host cells |
| 06/02/2009 | US7541446 Transcriptional activator fusion proteins which comprises both tetracycline controlled transactivator proteins and reverse tetracycline transactivator proteins |
| 06/02/2009 | US7541441 Antibodies that specifically bind to TL5 |
| 06/02/2009 | US7541438 Monoclonal antibody against connective tissue growth factor and medicinal uses thereof |
| 06/02/2009 | US7541435 Antagonists of cxcr3-binding cxc chemokines |
| 06/02/2009 | US7541432 L-glutamate-gated chloride channel proteins from Rhipicephalus sanguineus |
| 06/02/2009 | US7541344 Modulation of survivin expression |
| 06/02/2009 | US7541343 Antiproliferative agents; administering protein; restenosis, atherosclerosis; cancer |
| 06/02/2009 | US7541188 Comprising BSA, isoproterenol, carnitine, serine, oleic acid, linoleic acid, arachidonic acid, alpha -tocopherol, ascorbic acid, and EGF; for irritancy testing |
| 06/02/2009 | US7541187 Method of providing a substrate with a ready-to-use, uniformly distributed extracellular matrix |
| 06/02/2009 | US7541186 antagonist of bone morphogenetic protein (BMP) signaling pathways; antagonist of wnt signaling pathways; and IGF1R (Insulin-like growth factor-1 ) agonist, in the absence of basic fibroblast growth factor (FGF2) activity |
| 06/02/2009 | US7541185 Methods for identifying factors for differentiating definitive endoderm |
| 06/02/2009 | US7541184 Activation and expansion of cells |
| 06/02/2009 | US7541183 Growth and differentiation of adult muscle stem cells with activators or inhibitors of Wnt signaling |
| 06/02/2009 | US7541182 Using fatty acid synthase specific immunoglbulins as tool in diagnosis of late pregnancy toxemia |
| 06/02/2009 | US7541179 Vector encoding human globin gene and use thereof in treatment of hemoglobinopathies |
| 06/02/2009 | US7541172 DNA sequence encoding a polypeptide having the biological activity of amorpha-4,11-diene synthase, which is used to produce the specific precursor in the synthesis of artemisinin |
| 06/02/2009 | US7541168 Recombinant cyclopentanone monooxygenase [cpmo] |
| 06/02/2009 | US7541164 Mammalian cell culture processes for protein production |
| 06/02/2009 | US7541154 GASP1: a follistatin domain containing protein |
| 06/02/2009 | US7541143 Homo-doubly labeled compositions for the detection of enzyme activity in biological samples |
| 06/02/2009 | US7541031 Methods for treating rheumatoid arthritis using human antibodies that bind human TNFα |
| 06/02/2009 | US7541029 Anti-rhesus D monoclonal antibodies |
| 06/02/2009 | US7541025 Infusion of leukocytes into tumor; side efect reduction; then performing radiation therapy; prevent graft versus host disease |
| 06/02/2009 | US7540963 Compact device and methods for generating an ultrafiltrate, both of which can be used for a variety of applications, including, but not limited to filtering blood, diagnostic applications, and as a bioreactor; medical diagnosis; porous membrane |